argenx SE (ARGX) Cash Flow Statement

NASDAQ: ARGXOperating cash, capex, free cash flow and buybacks.

Where ARGX’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
$850.5M
Capital expenditures
$6.2M
0.1% of revenue
Free cash flow
$844.3M
20.3% margin
Returned to shareholders
—
Change in cash
$1.99B
cash at year-end $3.49B
Cash from operations: $850.5MCash from operations$850.5MInvestments (net): $939.5MInvestments (net)$939.5MOther financing: $237.8MOther financing$237.8MCurrency & other: $83.3MCurrency & other$83.3MAcquisitions & other: $109.5MAcquisitions & other$109.5M · 5%Added to cash: $1.99BAdded to cash$1.99B · 94%Capital expenditures, Debt repayment: $10.3MOther uses$10.3M · 0%$2.11B
Cash from operations
$850.5M
Capital expenditures
−$6.2M
Investments (net)
+$939.5M
Acquisitions & other
−$109.5M
Net borrowing (repayment)
−$4.1M
Other financing
+$237.8M
Currency & other
+$83.3M
Change in cash
$1.99B

Drawn to scale: where the cash came from and how it was used. Hover for values.

ARGX operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

ARGX cash flow trends, 2024–2025

argenx SE cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$82.7M2024$850.5M2025—
Capital expenditures$68.3M2024$6.2M2025−90.9%/yr
Free cash flow−$151.0M2024$844.3M2025—
Free cash flow margin−6.9%202420.3%2025+27.2 pts
Operating cash flow / net income−0.1020240.812025+0.91
Stock-based compensation$235.2M2024$248.1M2025+5.5%/yr
Capex / revenue3.1%20240.1%2025−3.0 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ARGX cash flow by activity

OperatingInvestingFinancingChange in cash

ARGX net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

ARGX cash flow statement

argenx SE annual cash flow statement
20252024
Operating activities
Net income$1.05B$833.0M
Depreciation & amortization$28.1M$17.5M
Stock-based compensation$248.1M$235.2M
Change in working capital−$423.9M−$324.6M
Other non-cash items−$55.6M−$843.9M
Cash from operating activities$850.5M−$82.7M
Investing activities
Capital expenditures−$6.2M−$68.3M
Investments (net)$939.5M−$717.6M
Acquisitions & other investing−$109.5M$68.3M
Cash from investing activities$823.9M−$717.6M
Financing activities
Share repurchases & issuance (net)—−$21.9M
Net borrowing (repayment)−$4.1M−$7.6M
Shares issued$0$0
Other financing$237.8M$309.3M
Cash from financing activities$233.7M$279.8M
Summary
Net change in cash$1.99B−$548.9M
Cash at end of period$3.49B$1.50B
Free cash flow$844.3M−$151.0M
Free cash flow margin20.3%−6.9%
Capex / revenue0.1%3.1%
Operating cash flow / net income0.81−0.10

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

ARGX cash generation

In fiscal 2025 (ended December 31, 2025), argenx generated $850.5 million of cash from operations and spent $6.2 million on capital expenditures, leaving free cash flow of $844.3 million, 20.3% of revenue. Cash and equivalents rose by $2.0 billion over the year.

Related: ARGX income statement, ARGX balance sheet. See the ARGX stock overview for the latest quote and news.

ARGX cash flow FAQ

What is argenx's free cash flow?

argenx's free cash flow was $844.3 million in fiscal 2025: $850.5 million of operating cash flow minus $6.2 million of capital expenditures It was -$151.0 million a year earlier..

How much cash does argenx generate from operations?

argenx generated $850.5 million of cash from operating activities in fiscal 2025, 0.81 times its net income of $1.1 billion.

How much does argenx spend on capital expenditures?

argenx spent $6.2 million on capital expenditures in fiscal 2025, 0.1% of revenue, compared with $68.3 million the year before.

Biotechnology: cash flow